The therapeutic regimen of RA patients primarily consists of nonsteroidal anti-inflammatory drugs (NSAIDs), glucocorticoids, methotrexate, and newer remedies such as tumor necrosis factor-α (TNF-α) inhibitors and Janus kinase inhibitors [8]. The gene discussed is TNF; the disease is rheumatoid arthritis.